-- Beach Energy（ASX：BPT）第三財季的業績顯示，其產量低於預期，且下調了產量指引。 Euroz Hartleys週三在一份報告中指出，這促使該公司將產量預測調整至更新後的指引中位數。 不過，Euroz Hartleys也指出，Waitsia專案的年化產量以及Otway盆地在第四財季的客戶提名情況，為該公司產量指引的上限提供了潛在提升空間。 Beach Energy週二將2026財年的產量指引從先前的1,970萬至2,200萬桶油當量下調至1,940萬至2,030萬桶油當量。 關於Waitsia互換安排的更多揭露，使前景更加明朗，促使該研究公司上調了對該公司2027至2029財年的獲利預測。 Euroz Hartleys先前將所有互換交易都設定為以實物形式返還，但現在指出，其中超過一半是可產生收益的回售安排。 該公司維持對Beach Energy的「持有」評級，同時根據更新後的分部估值法，將目標股價從每股1.18澳元下調至1.15澳元。 Beach Energy股價在周三的交易中下跌了1%。
Related Articles
Research
Research Alert: Gsk Q1 Beat As Specialty Medicines Remains Strong, Reiterates 2026 Outlook
CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:GSK delivered a Q1 2026 beat with sales growing 2% Y/Y (5% CER), led by Specialty Medicines (+10% or +14% CER), particularly oncology with strong Jemperli and Ojjaara uptake, while Vaccines grew 4% CER on record Shingrix sales. Core EPS grew 4% or 9% CER to GBP0.465, ahead of the consensus of GBP0.44, supported by a favorable product mix and cost control that lifted the core operating margin by 1.0%-pt or 1.8%-pts CER. We view the Q1 update positively given the beat and margin expansion, though we are mindful of currency headwinds. GSK reiterated its 2026 guidance for 3%-5% sales growth and 7%-9% core operating profit growth (CER), which is broadly aligned with that of several peers like Sanofi and Roche despite implying slower growth versus 2025. We expect revenue to be supported by key Specialty Medicines products, with GSK targeting the segment to contribute more than 50% of sales by 2031 (Q1 2026: 42%), while recent acquisitions provide a much-needed boost to growth and the drug pipeline, in our view.
$GSK
Asia
Gamuda Unit Bags Nearly MYR6 Billion Project from Sabah State Water Department
Gamuda (KLSE:GAMUDA) unit Upper Padas Power received a Letter of Acceptance worth 5.98 billion ringgit from the Sabah State Water Department for Phase 1 of the Skim Bekalan Air Ulu Padas.The project forms a bolt-on development linked to the Ulu Padas Hydroelectric Project and is designed to strengthen water supply for Sabah's west coast, according to a Wednesday Malaysian bourse filing.Phase 1 involves the construction of a 350 million litres per day water treatment plant in Beaufort, along with about 200km of pipelines stretching from Sipitang to Kota Kinabalu.The project marks a key infrastructure expansion alongside its hydroelectric development in Sabah, Malaysia, the company said.
$KLSE:GAMUDA
Equities
Aker Solutions to Develop Framed Modules Components for Rolls-Royce SMR
Aker Solutions (AKSO.OL) secured a deal to develop non-nuclear parts of framed modules for Rolls-Royce (RR.L) unit Rolls-Royce SMR, according to a Wednesday release.Under a memorandum of understanding, the Norwegian energy-focused engineering group will work with Rolls-Royce SMR to define the design and scope, and modularization approach for customer projects in the UK and other countries, with an initial focus on the UK and the Czech Republic.
$AKSO.OL$RR.L